The MENA (the Middle East and North Africa) region is mostly an untouched market, which is an impetus for potential development and lucrative growth in the pharmaceutical market. The MENA region, a gamut of 22 countries, represent about 2% of the world’s pharmaceutical market. Out of which, Saudi Arabia, a country which has an inclination towards innovative and expensive branded products, accounts for the largest market share. Other countries such as Nigeria, Tunisia, Morocco, and Algeria are also advancing steadily in the pharmaceutical domain by establishing local pharmaceutical manufacturing organizations.
The increasing advancements across the pharma value cha...
